Palvella Therapeutics (PVLA) Stock
Palvella Therapeutics (PVLA) closed at $144.60 on Nov 16, 2026; its Tenet Score is 34 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $144.60
- Nov 16, 2026
- Market cap
- $1.6B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Dividend yield
- 0.00%
- reinvests all
- 52-week range
- 72.22 – 179.95
- low → high
- Tenet Score
- 34/100
- Weak · 409 Healthcare peers
Industry: Pharmaceutical Preparations · see every company filed here →
Palvella Therapeutics, Inc. scores 34/100. Weak. Strongest on financial health, value is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 34 is built from 3 of 4 pillars, from 50% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=409Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ~ Drawdown Context
- ✕ Reversal Evidence
- ✓ Not-a-Value-Trap Gate
Pays no dividend. Every dollar of profit is reinvested into the business.
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipel…
Similar-sized companies in Pharmaceutical Preparations
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Veradermics IncMANE | 76 | $2.5B |
| Septerna Inc.SEPN | 56 | $2.0B |
| Hyperliquid Strategies Inc.PURR | 83 | $1.9B |
| Zenas Biopharma Inc.ZBIO | 28 | $1.9B |
| Kailera Therapeutics Inc.KLRA | 56 | $1.7B |
| Generate Biomedicines IncGENB | 28 | $1.6B |
| Rapport Therapeutics Inc.RAPP | 56 | $1.6B |
| LB Pharmaceuticals IncLBRX | 64 | $1.4B |
| Avalyn Pharma Inc.AVLN | 50 | $1.3B |
| Alto Neuroscience Inc.ANRO | 53 | $1.2B |
Common questions
What sector and industry is Palvella Therapeutics in?
Palvella Therapeutics is in the Healthcare sector and the Pharmaceutical Preparations industry.
What is Palvella Therapeutics' Tenet Score?
Palvella Therapeutics' Tenet Score is 34 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




